Education
About Us
Working with TipRanks
Follow Us
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
NASDAQ:GPCR
Total Valuation
Structure Therapeutics, Inc. Sponsored ADR has a market cap or net worth of $4.12B. The enterprise value is $2.56B.
Market Cap$4.12B
Enterprise Value$2.56B
Share Statistics
Structure Therapeutics, Inc. Sponsored ADR has 70,841,810 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding70,841,810
Owned by Insiders9.26%
Owned by Institutions11.94%
Financial Efficiency
Structure Therapeutics, Inc. Sponsored ADR’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -18.88%.
Return on Equity (ROE)-0.09
Return on Assets (ROA)-0.09
Return on Invested Capital (ROIC)-18.88%
Return on Capital Employed (ROCE)-0.19
Revenue Per Employee0.00
Profits Per Employee-866.27K
Employee Count163
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Structure Therapeutics, Inc. Sponsored ADR is 31.2. Structure Therapeutics, Inc. Sponsored ADR’s PEG ratio is -11.37.
PE Ratio31.2
PS Ratio0.00
PB Ratio2.72
Price to Fair Value2.72
Price to FCF-18.23
Price to Operating Cash Flow-15.51
PEG Ratio-11.37
Income Statement
In the last 12 months, Structure Therapeutics, Inc. Sponsored ADR had revenue of 0.00 and earned -141.20M in profits. Earnings per share was -2.40.
Revenue0.00
Gross Profit-3.90M
Operating Income-287.57M
Pretax Income-140.69M
Net Income-141.20M
EBITDA-136.79M
Earnings Per Share (EPS)-2.40
Cash Flow
In the last 12 months, operating cash flow was -222.20M and capital expenditures -3.61M, giving a free cash flow of -225.81M billion.
Operating Cash Flow-222.20M
Free Cash Flow-225.81M
Free Cash Flow per Share-3.19
Dividends & Yields
Structure Therapeutics, Inc. Sponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.23
52-Week Price Change171.71%
50-Day Moving Average73.58
200-Day Moving Average39.54
Relative Strength Index (RSI)30.98
Average Volume (3m)853.35K
Important Dates
Structure Therapeutics, Inc. Sponsored ADR upcoming earnings date is May 7, 2026, After Close (Confirmed).
Last Earnings DateFeb 26, 2026
Next Earnings DateMay 7, 2026
Ex-Dividend Date―
Financial Position
Structure Therapeutics, Inc. Sponsored ADR as a current ratio of 24.81, with Debt / Equity ratio of 0.43%
Current Ratio24.81
Quick Ratio24.81
Debt to Market Cap<0.01
Net Debt to EBITDA5.80
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Structure Therapeutics, Inc. Sponsored ADR has paid 515.00K in taxes.
Income Tax515.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Structure Therapeutics, Inc. Sponsored ADR EV to EBITDA ratio is -24.30, with an EV/FCF ratio of -14.72.
EV to Sales0.00
EV to EBITDA-24.30
EV to Free Cash Flow-14.72
EV to Operating Cash Flow-14.96
Balance Sheet
Structure Therapeutics, Inc. Sponsored ADR has $1.45B in cash and marketable securities with $6.49M in debt, giving a net cash position of $1.44B billion.
Cash & Marketable Securities$1.45B
Total Debt$6.49M
Net Cash$1.44B
Net Cash Per Share$20.32
Tangible Book Value Per Share$25.62
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Structure Therapeutics, Inc. Sponsored ADR is $113.18, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$113.18
Price Target Upside94.47% Upside
Analyst ConsensusStrong Buy
Analyst Count12
Revenue Growth Forecast―
EPS Growth Forecast-64.91%